Brain Scientific Inc.
BRSF
$0.75
-$0.35-31.82%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 41.48% | -146.38% | -124.30% | -230.26% | -707.22% |
| Total Depreciation and Amortization | 11.90% | 1,993.75% | 2,993.85% | 3,686.79% | 1,117.18% |
| Total Amortization of Deferred Charges | 866.70% | -- | -- | -- | 103.07% |
| Total Other Non-Cash Items | -67.27% | -- | -- | 364.11% | 303.81% |
| Change in Net Operating Assets | 84.26% | -113.25% | 13.56% | 73.30% | -221.12% |
| Cash from Operations | 59.57% | -18.25% | -93.72% | -121.95% | -1,163.95% |
| Capital Expenditure | 71.43% | -106.19% | 88.24% | 67.66% | 33.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -101.00% | 96.32% | 98.73% | 67.66% | 2,017.11% |
| Total Debt Issued | -100.00% | -100.00% | 251.44% | -12.88% | 1,316.16% |
| Total Debt Repaid | 84.67% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.77% | -103.08% | 231.86% | -19.64% | 786.88% |
| Foreign Exchange rate Adjustments | 1,477.50% | -- | -- | -- | -671.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -288.71% | -38.42% | 535.06% | -170.03% | 698.35% |
